Monday, December 23, 2024
HomeTagsElsubrutinib

elsubrutinib

AbbVie Advances Phase 3 Clinical Trial of Upadacitinib to Treat Systemic Lupus Erythematosus

AbbVie announced key results from a phase 2 study of upadacitinib given as monotherapy, or in combination therapy (ABBV-599) with elsubrutinib, a kinase inhibitor...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics